Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 17/20 | 0.76 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.72 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL27267165 | 1.00 | CYP19A1 (0.76) | CYP19A1CYP11B1CYP26A1CYP3A4TSHR | |
| Oxalic Acid SCHEMBL9524494 | 0.91 | CYP19A1 (0.72) | CYP19A1CYP11B1CYP26A1 | |
| SCHEMBL3278049 | 0.85 | CYP19A1 (0.65) | CYP19A1CYP11B1CYP26A1CYP3A4TSHR | |
| Rac-Vorozole SCHEMBL29606650 | 0.84 | CYP19A1 (1.00) | CYP19A1CYP11B1 | |
| Rac-Vorozole SCHEMBL1552681 | 0.84 | CYP19A1 (1.00) | CYP19A1CYP11B1 | |
| [N-Methyl-11C]Vorozole SCHEMBL12171619 | 0.84 | CYP19A1 (1.00) | CYP19A1CYP11B1 | |
| Vorozole SCHEMBL29363602 | 0.84 | CYP19A1 (1.00) | CYP19A1CYP11B1 | |
| Vorozole SCHEMBL4554 | 0.84 | CYP19A1 (1.00) | CYP19A1CYP11B1 | |
| Rac-Vorozole SCHEMBL13223107 | 0.84 | CYP19A1 (1.00) | CYP19A1CYP11B1 | |
| Oxalic Acid SCHEMBL9524601 | 0.80 | CYP19A1 (0.48) | CYP19A1CYP11B1CYP3A4CYP11B2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1022184-C | Process for preparing (1 H-imidzol-1-ylmethyl) substituted benzotriazole derivatives | JANSSEN PHARMACEUTICA NV (BE) | 1993-09-22 | — | — | CN | disclosed |
| EP-0293978-B1 | (1H-AZOL-1-YLMETHYL)SUBSTITUTED BENZOTRIAZOLE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-09-15 | — | — | EP | disclosed |
| US-5039677-A | Estrogen inhibitor | JANSSEN PHARMACEUTICA N.V. (CA) | 1991-08-13 | — | — | US | disclosed |
| US-4943574-A | AROMATASE INHIBITORS, ESTROGEN DISORDERS | JANSSEN PHARMACEUTICA N.V. (BE) | 1990-07-24 | — | — | US | disclosed |
| CN-88103408-A | Process for preparing (1H-oxazol-1-ylmethyl) substituted benzotriazole derivatives | — | 1988-12-14 | — | — | CN | disclosed |